Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The case for aggressive lipid regulation

A M Gotto1

  • 1Cornell University Medical College, Ithaca, NY, USA.

Hospital Practice (1995)
|February 15, 1997
PubMed
Summary

Lowering cholesterol through diet or medication significantly reduces coronary heart disease (CHD) risk, morbidity, and mortality. Aggressive treatment is crucial for patients with existing CHD to lower LDL cholesterol to 100 mg/dL or less.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents.

Revista panamericana de salud publica = Pan American journal of public health·2001
Same author

Therapeutic impact of statin therapy in patients with low HDL cholesterol.

Current atherosclerosis reports·2000
Same author

Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.

The American journal of cardiology·2000
Same author

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Journal of the American College of Cardiology·2000
Same author

Risk reduction.

Circulation·2000
Same author

Case 1: a patient with elevated low-density lipoprotein cholesterol.

The American journal of cardiology·2000

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Coronary heart disease (CHD) risk is significantly reduced by lowering cholesterol levels.
  • Existing treatments for hyperlipidemia are underutilized in clinical practice.

Purpose of the Study:

  • To emphasize the importance of cholesterol reduction in managing CHD.
  • To advocate for aggressive antihyperlipidemic therapy in patients with established CHD.

Main Methods:

  • Review of existing data on cholesterol-lowering interventions and CHD outcomes.
  • Analysis of current prescribing patterns for antihyperlipidemic drugs.

Main Results:

  • Cholesterol reduction, via diet or drugs, shows a proportional decrease in CHD risk.
  • Lowering LDL cholesterol to 100 mg/dL or below is recommended for CHD patients.
  • Antihyperlipidemic drug underuse is identified as a significant issue.

Conclusions:

  • Aggressive lipid-lowering therapy is essential for patients with established CHD.
  • Achieving target LDL cholesterol levels can substantially decrease CHD morbidity and mortality.
  • Increased utilization of antihyperlipidemic medications is warranted.

Related Experiment Videos